who crossed over to letrozole from tamoxifen. § Results for the censored population (with 95% CI); excludes crossover patients. [12] ATAC: Arimidex, Tamozifen, Alone or in Combination ...

Research findings to be revealed today suggest that Arimidex could prevent threequarters of them from suffering a relapse. It appears to work significantly better than tamoxifen, the current ...

A pilot study using neuropsychological testing from the Arimidex, Tamoxifen, Alone or in Combination (ATAC) trial showed that patients receiving hormone therapy performed lower on processing speed ...

In fact, Arimidex and Femara are now approved for initial use in postmenopausal women with advanced breast cancer, rather than as a second-line of defense after Tamoxifen has failed. Arimidex has ...